Innoviva (INVA) EBT (2010 - 2026)

Innoviva (INVA) has 17 years of EBT data on file, last reported at $234.6 million in Q1 2026.

• Quarterly EBT rose 707.85% year-over-year to $234.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $421.9 million (up 260.2% YoY) and the FY2025 annual result came in at $326.9 million, up 1257061.54% from the prior year.
• EBT advanced to $234.6 million in Q1 2026, from -$17.1 million in the prior quarter.
• In the past five years, EBT ranged from a high of $351.6 million in Q3 2022 to a low of -$198.2 million in Q4 2024.
• A 5-year average of $45.5 million and a median of $20.5 million in 2022 frame the typical range for EBT.
• Annual changes were most pronounced in 2024 — EBT slumped 1847.08% — and 2025, when it surged 938.49%.
• Tracing INVA's EBT over 5 years: stood at -$15.9 million in 2022, then jumped by 36.0% to -$10.2 million in 2023, then tumbled by 1847.08% to -$198.2 million in 2024, then surged by 91.38% to -$17.1 million in 2025, then surged by 1472.36% to $234.6 million in 2026.
• The last three EBT figures came in at $234.6 million (Q1 2026), -$17.1 million (Q4 2025), and $131.8 million (Q3 2025), per Business Quant data.